ALNY vs VTSI · P/E 76, rev $1.29B vs rev $9.2M
Alnylam Pharmaceuticals Inc (ALNY) versus VirTra Inc (VTSI) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
VirTra Inc (VTSI) is a software - application company listed on NASDAQ.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported VTSI revenue for 2026-06-30 was $9.2M. Net income was -$1.6M. VTSI currently screens at market cap $38.4M.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. VTSI currently screens at market cap $38.4M.
Not investment advice. Open the ALNY and VTSI stock pages for the full models.
Not investment advice.